Helsinki - Delayed Quote EUR
Faron Pharmaceuticals Oy (FARON.HE)
At close: November 7 at 6:29 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
28,567.0000
28,567.0000
27,426.0000
21,109.0000
16,654.0000
Operating Income
-28,567.0000
-28,567.0000
-27,426.0000
-21,109.0000
-16,654.0000
Net Non Operating Interest Income Expense
-2,383.0000
-2,383.0000
-1,349.0000
-230.0000
-53.0000
Pretax Income
-30,944.0000
-30,944.0000
-28,730.0000
-21,178.0000
-16,934.0000
Tax Provision
--
--
--
16.0000
10.0000
Net Income Common Stockholders
-30,944.0000
-30,944.0000
-28,730.0000
-21,194.0000
-16,944.0000
Diluted NI Available to Com Stockholders
-30,944.0000
-30,944.0000
-28,730.0000
-21,194.0000
-16,944.0000
Basic EPS
-0.48
-0.48
-0.52
-0.42
-0.37
Diluted EPS
-0.48
-0.48
-0.52
-0.42
-0.37
Basic Average Shares
65,055.0360
65,055.0360
55,229.8350
50,723.9640
45,712.1110
Diluted Average Shares
65,055.0360
65,055.0360
55,229.8350
50,723.9640
45,712.1110
Total Operating Income as Reported
-28,568.0000
-28,568.0000
-27,426.0000
-21,108.0000
-16,654.0000
Rent Expense Supplemental
320.0000
320.0000
114.0000
7.0000
--
Total Expenses
28,567.0000
28,567.0000
27,426.0000
21,109.0000
16,654.0000
Net Income from Continuing & Discontinued Operation
-30,944.0000
-30,944.0000
-28,730.0000
-21,194.0000
-16,944.0000
Normalized Income
-30,944.0000
-30,944.0000
-28,730.0000
-21,194.0000
-16,944.0000
Interest Income
230.0000
230.0000
11.0000
2.0000
109.0000
Interest Expense
2,167.0000
2,167.0000
1,373.0000
215.0000
149.0000
Net Interest Income
-2,383.0000
-2,383.0000
-1,349.0000
-230.0000
-53.0000
EBIT
-28,777.0000
-28,777.0000
-27,357.0000
-20,963.0000
-16,785.0000
EBITDA
-28,431.0000
-28,431.0000
-27,057.0000
-20,657.0000
-16,502.0000
Reconciled Depreciation
346.0000
346.0000
300.0000
306.0000
283.0000
Net Income from Continuing Operation Net Minority Interest
-30,944.0000
-30,944.0000
-28,730.0000
-21,194.0000
-16,944.0000
Normalized EBITDA
-28,431.0000
-28,431.0000
-27,057.0000
-20,657.0000
-16,502.0000
Tax Rate for Calcs
--
--
--
0.0002
0.0002
12/31/2020 - 12/3/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HRTIS.HE Herantis Pharma Oyj
1.2800
-4.83%
NANOFH.HE Nanoform Finland Oyj
1.1600
+5.45%
52X.F Magle Chemoswed Holding AB (publ)
2.9600
-1.99%
24H.F Hansa Biopharma AB (publ)
2.7440
-3.72%
IMMU.ST Mendus AB (publ)
10.29
-2.41%
BIOBV.HE Biohit Oyj
2.4600
+3.36%
ABLI.ST Abliva AB (publ)
0.1526
-0.26%
SCOL.ST Scandion Oncology A/S
0.0800
-10.61%
ISOFOL.ST Isofol Medical AB (publ)
3.2550
-2.25%
SCLP.L Scancell Holdings plc
13.38
0.00%